nifedipine has been researched along with Hypoparathyroidism in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goswami, G | 1 |
Gurtoo, A | 1 |
Mayan, H | 1 |
Hourvitz, A | 1 |
Schiff, E | 1 |
Farfel, Z | 1 |
2 other studies available for nifedipine and Hypoparathyroidism
Article | Year |
---|---|
Hypertension and hypoparathyroidism--narrowed therapeutic safety with nifedipine.
Topics: Adult; Contraindications; Female; Humans; Hypertension; Hypocalcemia; Hypoparathyroidism; Hypotensio | 1993 |
Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.
Topics: Adult; Calcium; Female; Humans; Hypocalcemia; Hypoparathyroidism; Indomethacin; Magnesium; Nifedipin | 1999 |